Drugdiscovery >> Pharmaceutical Companies >> News
4225
Views
AstraZeneca links with privately held company to research cancer - drugdiscovery.com
AstraZeneca links with privately held company to research cancer - drugdiscovery.com


AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches.
Read More >>


Tags: T-cell, AstraZeneca, Immunocore, co-operation - January 16, 2014
Related Articles
6969
Views
Pfizer- The world's largest research-based pharmaceutical company Pfizer- The world's largest research-based pharmaceutical company
At Pfizer, science and global resources are applied in order to improve health and well-being at every stage of life. Read More >>

Tags: pfizer, pharmaceutical company

4289
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

1720
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

1668
Views
Continuing successful cooperation Continuing successful cooperation
A licensing deal signed between Cancer Research Technology, The Institute of Cancer Research, and Merck Serono, extends a successful initial alliance to discover and develop WNT pathway inhibitors to Read More >>

Tags: WNT pathway inhibitors, Cancer Research Technology, The Institute of Cancer Research, Merck Serono

4306
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

5225
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

3052
Views
AstraZeneca buys anti-diabetes giant AstraZeneca buys anti-diabetes giant
AstraZeneca PLC will buy out Bristol-Myers Squibb. This opens a new market for the anglo-swedish company to sell drugs. According to the company this helps to make diabetes drugs free and good Read More >>

Tags: AstraZeneca,Birstol Myers Squibb, diabeters

3197
Views
Astra Zeneca has signed a contract with the South Korean Government Astra Zeneca has signed a contract with the South Korean Government
A memorandum of understanding was signed by AstraZeneca and South Korean government. Korea guarantees to help some early-stage drug development projects. Read More >>

Tags: AstraZeneca, research, South Korea, memorandum of understanding

1596
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

6693
Views
Merck, AstraZeneca ovarian cancer drug deal Merck, AstraZeneca ovarian cancer drug deal
AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain form Read More >>

Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013